Lentioo

Drospirenone, the active ingredient in Lentioo, is a combined oral contraceptive presented as an oral tablet for oral use. It is used to prevent pregnancy and to regulate menstrual cycles in women of reproductive age.

GNH USA supplies Lentioo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent regulatory standards and offering comprehensive logistics support for global distribution.

Lentioo, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy and manage menstrual disorders.

- Contraception: provides reliable prevention of pregnancy when taken as prescribed. - Menstrual cycle regulation: helps achieve more predictable and lighter menstrual bleeding. - Acne treatment: may improve mild to moderate acne associated with hormonal fluctuations.

Lentioo may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Hypertensive disorders: severe high blood pressure or stroke. - Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Lentioo, clinicians should consider several safety considerations.

- Contraindications: avoid in women with a history of thromboembolic events, estrogen‑dependent tumors, or active liver disease. - Smoking: do not prescribe to smokers over 35 years due to increased cardiovascular risk. - Cardiovascular risk: assess for hypertension, hyperlipidaemia, or diabetes before initiation. - Medication adherence: emphasize daily intake at the same time to maintain efficacy. - Pregnancy: contraindicated in pregnancy; advise effective contraception. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Lentioo can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Combined hormonal contraceptives with other estrogen‑containing products: increased risk of thrombosis. - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., phenytoin, phenobarbital): may lower hormone levels, requiring additional contraception. - Antifungal agents (e.g., ketoconazole): may increase hormone concentrations, raising side‑effect risk. - St. John’s wort: may decrease contraceptive effectiveness.